xtantmedical.com - XTNT Short-Term Debt to Capital

The debt-to-equity chart for Xtant Medical Holdings (XTNT) is currently at 0.41. Xtant Medical Holdings (XTNT) produces orthopedic bio-implants, minimizing supply chain disruptions through a network of backup hubs. Additionally, the business develops tissue regeneration products by implementing energy-efficient sterilization and eco-friendly packaging. Sales growth for spinal surgery systems is driven by the expansion of independent distributors across US regions.

Assessing the financial stability of Xtant Medical (XTNT) requires analyzing the balance between debt and equity to ensure the development of vertically integrated implant production. This metric measures the proportion of short-term liabilities within the capital structure; by examining the historical trend of short-term loans relative to equity, an investor determines the liquidity risk and the company's ability to fund regenerative solutions without diluting shareholder value.